Orthofix Medical (OFIX) Stock Price, News & Analysis

Company Overview

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Key Stats

• Today's Range: $15.86 to $16.31
• 50-Day Range: $16.06 to $19.04
• 52-Week Range: $12.08 to $20.73
• Volume: 150,950 shs
• Average Volume: 258,356 shs
• Market Capitalization: $626.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $23.33
• Consensus Rating: Moderate Buy

Orthofix Medical Stock Analysis - MarketRank™

Orthofix Medical scored higher than 61% of companies evaluated by MarketBeat, and ranked 408th out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Orthofix Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Orthofix Medical has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Orthofix Medical are expected to grow in the coming year, from ($2.81) to ($1.32) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Orthofix Medical is -5.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Orthofix Medical is -5.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Orthofix Medical has a P/B Ratio of 1.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.64% of the float of Orthofix Medical has been sold short.

Short Interest Ratio / Days to Cover

Orthofix Medical has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Orthofix Medical has recently increased by 0.07%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Orthofix Medical does not currently pay a dividend.

Dividend Growth

Orthofix Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.64% of the float of Orthofix Medical has been sold short.

Short Interest Ratio / Days to Cover

Orthofix Medical has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Orthofix Medical has recently increased by 0.07%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 1.30

News Sentiment

Orthofix Medical has a news sentiment score of 1.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Orthofix Medical this week, compared to 7 articles on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Orthofix Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $512,497.00 in company stock.

Percentage Held by Insiders

Only 2.60% of the stock of Orthofix Medical is held by insiders.

Percentage Held by Institutions

89.76% of the stock of Orthofix Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

OFIX Stock Analysis - Frequently Asked Questions

How have OFIX shares performed this year?

Orthofix Medical's stock was trading at $17.46 at the beginning of the year. Since then, OFIX stock has decreased by 8.0% and is now trading at $16.06.
View the best growth stocks for 2025 here.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc. (NASDAQ:OFIX) released its earnings results on Thursday, November, 7th. The medical device company reported ($0.71) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by $0.57. The medical device company earned $196.61 million during the quarter, compared to the consensus estimate of $196.60 million. Orthofix Medical had a negative trailing twelve-month return on equity of 21.25% and a negative net margin of 15.18%.

Who are Orthofix Medical's major shareholders?

Top institutional shareholders of Orthofix Medical include Engine Capital Management LP (9.03%), Paradigm Capital Management Inc. NY (6.51%), Vanguard Group Inc. (5.57%) and Juniper Investment Company LLC (5.07%). Insiders that own company stock include Kevin J Kenny, Geoffrey C Gillespie, Julie Andrews and Shweta Maniar.
View institutional ownership trends.

How do I buy shares of Orthofix Medical?

Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Orthofix Medical investors own include Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Netflix (NFLX) and Visa (V).

Company Calendar

• Last Earnings: 11/07/2024
• Today: 3/30/2025
• Next Earnings (Estimated): 5/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Health Care Equipment
• Current Symbol: NASDAQ:OFIX
• CIK: 884624
• Web: www.orthofix.com
• Phone: (214) 937-2000
• Fax: 599 9 461 6978
• Employees: 1,090
• Year Founded: 1980

Price Target and Rating

• Average Stock Price Target: $23.33
• High Stock Price Target: $24.00
• Low Stock Price Target: $22.00
• Potential Upside/Downside: +45.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.80
• Research Coverage: 5 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($3.29)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-151,400,000.00
• Net Margins: -15.18%
• Pretax Margin: -14.82%
• Return on Equity: -21.25%
• Return on Assets: -13.29%

Debt

• Debt-to-Equity Ratio: 0.25
• Current Ratio: 2.39
• Quick Ratio: 1.11

Sales & Book Value

• Annual Sales: $799.49 million
• Price / Sales: 0.78
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $16.11 per share
• Price / Book: 1.00

Miscellaneous

• Outstanding Shares: 39,022,000
• Free Float: 37,220,000
• Market Cap: $626.69 million
• Optionable: Optionable
• Beta: 1.06